Cargando…

Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards

Introduction: Prescribing antibiotics to newborns is challenging, as excess antibiotics are a risk factor for increased morbidity and mortality. The objective of this study was to describe the evolution of antibiotic exposure over three years in a large network of level 3 neonatal wards where each c...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Mons, Séverine, Lorrain, Simon, Iacobelli, Silvia, Gouyon, Béatrice, Gouyon, Jean-Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868323/
https://www.ncbi.nlm.nih.gov/pubmed/33568992
http://dx.doi.org/10.3389/fphar.2020.585018
_version_ 1783648429310738432
author Martin-Mons, Séverine
Lorrain, Simon
Iacobelli, Silvia
Gouyon, Béatrice
Gouyon, Jean-Bernard
author_facet Martin-Mons, Séverine
Lorrain, Simon
Iacobelli, Silvia
Gouyon, Béatrice
Gouyon, Jean-Bernard
author_sort Martin-Mons, Séverine
collection PubMed
description Introduction: Prescribing antibiotics to newborns is challenging, as excess antibiotics are a risk factor for increased morbidity and mortality. The objective of this study was to describe the evolution of antibiotic exposure over three years in a large network of level 3 neonatal wards where each center is informed yearly of its own results and the results of other centers and has full autonomy to improve its performance. Patients and Methods: This is a prospective, observational study of antibiotics prescriptions over the 2017–2019 period in a network of 23 French level 3 neonatal wards. The network relied on an internal benchmarking program based on a computerized prescription ordering system. Among others, antibiotics exposure, treatment duration, and antibiotics spectrum index were analyzed. Results: The population consisted of 39,971 neonates (51.5% preterm), 44.3% of which were treated with antibiotics. Of the treated patients, 78.5% started their first antibiotic treatment in the first three days of life. Antibiotic exposure rate significantly declined from 2017 to 2019 (from 46.8% to 42.8%, p < 0.0001); this decline was significant in groups with gestational age >26 weeks, but not in the group with extremely low gestational age <27 weeks. Gentamicin, cefotaxime, amoxicillin (ampicillin), vancomycin, and amikacin were the antibiotics most prescribed. The lower the gestational age, the higher the exposure for cefotaxime, vancomycin, and amikacin. Compared to 2017, cefotaxime exposure in 2019 declined by 12.6%, but the change was only significant in the gestational age group of 32–36 weeks (17.4%) and at term (20.3%). The triple combination of antibiotics in the first three days decreased by 28.8% from 2017 to 2019, and this was significant in each gestational age group. During the study, the delayed ending of antibiotics in unconfirmed early-onset neonatal infection increased from 9.6% to 11.9%. Conclusion: This study showed that a strategy characterized by the collection of information via a computerized order-entry system, analysis of the results by a steering committee representative of all neonatal wards, and complete autonomy of neonatal wards in the choice of prescription modalities, is associated with a significant reduction in the use of antibiotics in newborns with gestational age greater than 26 weeks.
format Online
Article
Text
id pubmed-7868323
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78683232021-02-09 Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards Martin-Mons, Séverine Lorrain, Simon Iacobelli, Silvia Gouyon, Béatrice Gouyon, Jean-Bernard Front Pharmacol Pharmacology Introduction: Prescribing antibiotics to newborns is challenging, as excess antibiotics are a risk factor for increased morbidity and mortality. The objective of this study was to describe the evolution of antibiotic exposure over three years in a large network of level 3 neonatal wards where each center is informed yearly of its own results and the results of other centers and has full autonomy to improve its performance. Patients and Methods: This is a prospective, observational study of antibiotics prescriptions over the 2017–2019 period in a network of 23 French level 3 neonatal wards. The network relied on an internal benchmarking program based on a computerized prescription ordering system. Among others, antibiotics exposure, treatment duration, and antibiotics spectrum index were analyzed. Results: The population consisted of 39,971 neonates (51.5% preterm), 44.3% of which were treated with antibiotics. Of the treated patients, 78.5% started their first antibiotic treatment in the first three days of life. Antibiotic exposure rate significantly declined from 2017 to 2019 (from 46.8% to 42.8%, p < 0.0001); this decline was significant in groups with gestational age >26 weeks, but not in the group with extremely low gestational age <27 weeks. Gentamicin, cefotaxime, amoxicillin (ampicillin), vancomycin, and amikacin were the antibiotics most prescribed. The lower the gestational age, the higher the exposure for cefotaxime, vancomycin, and amikacin. Compared to 2017, cefotaxime exposure in 2019 declined by 12.6%, but the change was only significant in the gestational age group of 32–36 weeks (17.4%) and at term (20.3%). The triple combination of antibiotics in the first three days decreased by 28.8% from 2017 to 2019, and this was significant in each gestational age group. During the study, the delayed ending of antibiotics in unconfirmed early-onset neonatal infection increased from 9.6% to 11.9%. Conclusion: This study showed that a strategy characterized by the collection of information via a computerized order-entry system, analysis of the results by a steering committee representative of all neonatal wards, and complete autonomy of neonatal wards in the choice of prescription modalities, is associated with a significant reduction in the use of antibiotics in newborns with gestational age greater than 26 weeks. Frontiers Media S.A. 2021-01-25 /pmc/articles/PMC7868323/ /pubmed/33568992 http://dx.doi.org/10.3389/fphar.2020.585018 Text en Copyright © 2021 Martin-Mons, Lorrain, Iacobelli, Gouyon and Gouyon. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Martin-Mons, Séverine
Lorrain, Simon
Iacobelli, Silvia
Gouyon, Béatrice
Gouyon, Jean-Bernard
Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title_full Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title_fullStr Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title_full_unstemmed Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title_short Antibiotics Prescription Over Three Years in a French Benchmarking Network of 23 Level 3 Neonatal Wards
title_sort antibiotics prescription over three years in a french benchmarking network of 23 level 3 neonatal wards
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868323/
https://www.ncbi.nlm.nih.gov/pubmed/33568992
http://dx.doi.org/10.3389/fphar.2020.585018
work_keys_str_mv AT martinmonsseverine antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards
AT lorrainsimon antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards
AT iacobellisilvia antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards
AT gouyonbeatrice antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards
AT gouyonjeanbernard antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards
AT antibioticsprescriptionoverthreeyearsinafrenchbenchmarkingnetworkof23level3neonatalwards